5 Biotechs Awaiting FDA Decisions in January 2018 Post author:Sam Post published:December 27, 2017 Post category:BioPharma From 1997 through 2013, there was an average of 27 novel drugs approved in the U.S. per year. Source: BioSpace You Might Also Like How AstraZeneca PLC's Silence Led to a $4 Billion Loss Overnight July 13, 2017 Prometic Snags Rare Pediatric Disease Designation from the FDA for its Inter-Alpha-Inhibitor-Prot… March 4, 2018 Pfizer to Cut 300 Jobs as It Ends Alzheimer's, Parkinson's Quest January 7, 2018
Prometic Snags Rare Pediatric Disease Designation from the FDA for its Inter-Alpha-Inhibitor-Prot… March 4, 2018